Search

everythinglearnresearchcommunity

for

Search:↓

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

Stopping imipramine reduced the woman's hair loss.

Alopecia areata in Taif is common, mainly immune-related, and best treated with topical corticosteroids and vitamins.

Alopecia areata may be caused by the immune system attacking hair follicles.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Alopecia causes patchy hair loss and can be diagnosed with new techniques; treatments like strong creams and contact immunotherapy can help.

Oral cyclosporine works better than betamethasone minipulse therapy for treating Alopecia Areata.

Differences in skin and gut bacteria may contribute to alopecia areata.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

COVID-19 infection may trigger alopecia areata in some patients.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Type I interferons play a key role in the development of various skin diseases.

Ginkgo biloba polysaccharides may reduce inflammation and promote hair growth in mice with hair loss.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.